Records containing: Nocturia
This is the wording recorded or indexed by the source. An agency index term is not necessarily an authorised indication. Co-listed drug names are not linked to this term as a treatment relationship.
Follow recorded terms in Drug Alerts for Android. Free includes unlimited local condition follows and an on-open recent-record watchlist. Plus adds no ads and personal organization tools.
All
FDA submission records
EMA medicine records
ClinicalTrials.gov record updates
ClinicalTrials.gov records with results posted
-
CLINICAL_TRIALS study record update · 2018-10-31A Double-blind, Placebo-controlled Dose Response Study to Investigate Pharmacodynamics and Pharmacokinetics of Single and Repeated Oral Doses of VA106483 in Elderly Male Subjects
-
CLINICAL_TRIALS study record update · 2018-09-17A Multi-Centre Trial Investigating the Long Term Safety and Tolerability of Desmopressin (FE 992026) Orally Disintegrating Tablets for the Treatment of Nocturia Due to Nocturnal Polyuria in Japanese Subjects
-
CLINICAL_TRIALS study record update · 2018-05-23An Open Label, Escalation Study to Assess Intra-Subject Dose Response to VA106483 in Elderly Male Subjects
-
CLINICAL_TRIALS study record update · 2018-03-20Effect of Prostatic Urethral Lift (PUL) Versus Prostate Arterial Embolization (PAE),Novel Minimally Invasive Treatment Options on Health-related Quality of Life (HRQoL) in Men With Lower Urinary Tract Symptoms Secondary to BPH.
-
CLINICAL_TRIALS study record update · 2018-01-10Behavioral Therapy to Treat Urinary Symptoms in Parkinson Disease
- Organize your saved records without ads with Plus.
-
CLINICAL_TRIALS study record update · 2017-06-02Spanish (Spain) Validation of a Specific Symptomatic Questionnaire for Patients With Nocturia
-
CLINICAL_TRIALS study record update · 2017-05-05A Double-blind, Randomized, Placebo-controlled Study Investigating the Impact Burden of Nocturia Using the Nocturia Impact Diary
-
CLINICAL_TRIALS study record update · 2017-03-24A Double-Blind, Placebo-Controlled, Cross-over Study of Armodafinil Treatment of Daytime Sleepiness Associated With Treated Nocturia
-
CLINICAL_TRIALS study record update · 2017-03-10A Multi-center, Prospective, Open-label, Single-arm, 12-weeks, Phase IV Trial to Evaluate the Efficacy and Safety of Silodosin on Nocturia for Patients With Benign Prostatic Hyperplasia
-
CLINICAL_TRIALS study record update · 2017-01-02Efficacy and Safety of Gabapentin in Treating Overactive Bladder
-
CLINICAL_TRIALS study record update · 2016-11-15A Randomized Double-blinded Trial Comparing DEsmopressin to FEsoterodine in the Treatment of Severe Nocturia in Women Aged 65 and olDer: The DEFEND Trial
-
CLINICAL_TRIALS study record update · 2016-10-14An Open-Label, 2-Part Sequential Dose Study Designed to Assess the Absolute Bioavailability, Mass Balance Recovery, Metabolite Profile and Metabolite Identification of [14C]-SK-1404 Administered to Healthy Male Subjects
-
CLINICAL_TRIALS study record update · 2016-06-02Severe Pelvic Organ Prolapse and Post-Obstructive Diuresis (SOPPO) Pilot Study
-
CLINICAL_TRIALS study record update · 2016-05-24A Prospective Safety Study in 24 Months Treatment of Nocturia With Minirin Melt in Clinical Practice in the Czech Republic
-
CLINICAL_TRIALS study record update · 2016-05-05The Effect of Urox™(Crateva, Horsetail and Lindera Combination) in the Treatment of Overactive Bladder and Urinary Incontinence
-
CLINICAL_TRIALS study record update · 2016-04-13ClinicalTrials.gov study NCT01018225
-
CLINICAL_TRIALS study record update · 2015-12-15A Multi-Center Extension Study Investigating the Long Term Efficacy and Safety of a Fast-Dissolving ("Melt") Formulation of Desmopressin for the Treatment of Nocturia in Adults
-
CLINICAL_TRIALS study record update · 2015-11-02A Randomized, Double Blind, Placebo Controlled, Parallel Group, Multi-Center Study With a Double Blind Extension Investigating the Efficacy and Safety of a Fast- Dissolving ("Melt") Formulation of Desmopressin for the Treatment of Nocturia in Adults
-
CLINICAL_TRIALS study record update · 2015-10-15A Multi-centre, Randomised, Double-blind, Placebo-controlled, Parallel-group Trial With an Open-label Extension to Demonstrate the Efficacy and Safety of Desmopressin Orally Disintegrating Tablets for the Treatment of Nocturia in Adult Males
-
CLINICAL_TRIALS study record update · 2015-10-15A Multi-centre, Randomised, Double-blind, Placebo-controlled, Parallel-group Trial to Demonstrate the Efficacy and Safety of Desmopressin Orally Disintegrating Tablet for the Treatment of Nocturia in Adult Females
-
CLINICAL_TRIALS study record update · 2015-07-30Single Center, Open-Label, Single-Sequence, Within-Subject Study In Two Cohorts Of Healthy Male Subjects Comparing Single-Dose Pharmacokinetics Of Fedovapagon Alone And In Combination With A CYP3A4 Inhibitor, Itraconazole, Or A CYP3A4 Inducer, Rifampicin
-
CLINICAL_TRIALS study record update · 2015-04-27A Double-blind, Randomised, Parallel-group Trial Investigating Sleep Behaviour and Daytime Performance in Nocturia Patients Treated With Desmopressin Orally Disintegrating Tablets as Compared to Placebo
-
CLINICAL_TRIALS study record update · 2015-02-10Single-centre Open Label Exploratory Phase IIb Pilot Study of Exogenous Oral Melatonin for the Treatment of Nocturia in Adults With Parkinson's Disease
-
CLINICAL_TRIALS study record update · 2015-02-04Prospective, Randomized, Double-blind Trial of Desmopressin on Nocturia in Obstructive Sleep Apnoea Patients
-
CLINICAL_TRIALS study record update · 2014-12-11The Effect of Gender on Antidiuresis - Evaluated by Graded Low Dose Desmopressin Infusion